Trial Profile
The effect of chronotherapy with the angiotensin-antagonist in hypertension with sleep apnea syndrome.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Oct 2018
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 10 Oct 2018 Status changed from recruiting to completed.
- 26 Jul 2013 Planned End Date changed from 1 Aug 2015 to 1 Apr 2015 as reported by University Hospital Medical Information Network - Japan record.
- 18 Jan 2012 New trial record